Molybdenum is a mineral that is used as a supplement for sulfite sensitivity, cancer prevention, asthma, cavity prevention, allergies, and Wilson's disease.
Other names for Molybdenum include: Sodium Molybdate and Etrathiomolybdate.
Ask your doctor, nurse, or pharmacist if you need more information about this medicine or if any information in this leaflet concerns you.
Tell your doctor if you
Talk with your caregiver about how much Molybdenum you should take. The amount depends on the strength of the medicine and the reason you are taking Molybdenum. If you are using this medicine without instructions from your caregiver, follow the directions on the medicine bottle. Do not take more medicine or take it more often than the directions tell you to.
Keep all medicine locked up and away from children. Store medicine away from heat and direct light. Do not store your medicine in the bathroom, near the kitchen sink, or in other damp places. Heat or moisture may cause the medicine to break down and not work the way it should work. Throw away medicine that is out of date or that you do not need. Never share your medicine with others.
Do not take Molybdenum without talking to your doctor first if you are taking:
Stop taking your medicine right away and talk to your doctor if you have any of the following side effects. Your medicine may be causing these symptoms which may mean you are allergic to it.
You may have the following side effects, but this medicine may also cause other side effects. Tell your doctor if you have side effects that you think are caused by this medicine.
1. Murray, MT: Encyclopedia of Nutritional Supplements. Prima Publishing, Rocklin, CA; 1996.
2. Yang CS: Research on esophageal cancer in China: A review. Cancer Res 1980;40:2633-2644.
3. Lou XM, Wei HJ, & Yang SP: Inhibitory effect of molybdenum on esophageal and forestomach carcinogenesis in rats. J Natl Cancer Inst 1983;71:75-80.
4. Komada K, Kise Y, Nakagawa M et al: Effect of dietary molybdenum on esophageal carcinogenesis in rats in induced by N-methyl-N-benzylnitrosamine. Cancer Res 1990; 50:2418-2422.
5. Losee FL & Adkins BL: A study of the mineral environment of caries-resistant navy recruits. Caries Res 1969;3:223-31.
6. Jenkins GN: Molybdenum. In: Curzon MEJ & Cutress TW (eds): Trace Elements and Dental Disease. John Wright, Boston, MA; 1983:149-166.
7. Brewer GJ: Practical recommendations and new therapies for Wilson's disease. Drugs 1995;50:240-249.
8. Brewer GJ, et al: Treatment of Wilson's disease with ammonium tetrathiomolybdate; I, Initial therapy in 17 neurologically affected patients. Arch Neurol 1994;51:545-554.